J Vionnet

Author PubWeight™ 6.07^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.	J Clin Invest	1994	1.97
2	Elongation of alternating alpha 2,8/2,9 polysialic acid by the Escherichia coli K92 polysialyltransferase.	Glycobiology	2001	0.89
3	Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne's syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues.	Biochem Pharmacol	2000	0.83
4	Expression of an alternatively spliced ercc1 messenger-RNA species, is related to reduced DNA-repair efficiency in human T-lymphocytes.	Oncol Rep	1995	0.83
5	Peripheral blood leukocytes as a surrogate marker for cisplatin drug resistance: studies of adduct levels and the repair gene ERCC1.	Basic Life Sci	1990	0.83
6	Platinum-DNA adduct in head and neck-cancer patients receiving Cisplatin and Carboplatin chemotherapy.	Int J Oncol	1993	0.76
7	[Shingles vaccine: which recommendations in 2014?].	Rev Med Suisse	2014	0.75